🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Peter G. Rose

Cleveland Clinic

ORCID: 0000-0003-2676-0166

Also affiliated with University of Nottingham, Loughborough University, Cleveland Foundation, Case Western Reserve University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Mutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology study”.

Mutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology study

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.01.025
N/A
2.5DataRank · unranked
85 citations

Virginia L. Filiaci, Adrianne Mallen, Kristina W. Thiel, Eric J. Devor, Katherine Moxley +17 more

LCK facilitates DNA damage repair by stabilizing RAD51 and BRCA1 in the nucleus of chemoresistant ovarian cancer

Journal of Ovarian Research(2023)10.1186/s13048-023-01194-2
N/A
0.373DataRank · unranked
11 citations

Rashmi Bharti, Chad Braley, Ravi Kumar Alluri, Emily Esakov, Katie Crean-Tate +7 more

Development and validation of a comprehensive clinical risk-scoring model for prediction of overall survival in patients with endometrioid endometrial carcinoma

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.09.008
N/A
0.208DataRank · unranked
3 citations

Lisa Rybicki, Caitlin Carr, Meng Yao, Sudha Amarnath, Roberto Vargas +4 more

Disruption of the Gut Microbiota Attenuates Epithelial Ovarian Cancer Sensitivity to Cisplatin Therapy

Research Square(2021)10.21203/rs.3.rs-80626/v2
N/A
0.165DataRank · unranked
2 citations

Emily Esakov, Chad Braley, Lexie Trestan, Zahraa Alali, Defne Bayık +14 more

LCK Facilitates DNA Damage Repair by Stabilizing RAD51 and BRCA1 in the Nucleus of Chemoresistant Ovarian Cancer

Research Square(2022)10.21203/rs.3.rs-2223587/v1
N/A
0DataRank · unranked
0 citations

Goutam Dey, Rashmi Bharti, Chad Braley, Ravi Kumar Alluri, Emily Esakov +7 more

Comparing Durvalumab, Olaparib, and Cediranib Monotherapy, Combination Therapy, or Chemotherapy in Patients with Platinum-Resistant Ovarian Cancer with Prior Bevacizumab: The Phase II NRG-GY023 Trial

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-3877
N/A
0DataRank · unranked
8 citations

Austin Miller, Peter G. Rose, Mariam AlHilli, Christina Washington, Veena S. John +15 more

Disruption of the Gut Microbiota Attenuates Epithelial Ovarian Cancer Sensitivity to Cisplatin Therapy

Research Square(2020)10.21203/rs.3.rs-80626/v1
N/A
0DataRank · unranked
2 citations

Emily Esakov, Chad Braley, Lexie Trestan, Zahraa Alali, Peter Bazeley +13 more

Molecular Profiling and Tumor Biomarker Analysis of GOG281/LOGS: A Positive Late-Phase Trial of Trametinib for Recurrent/Persistent Low-Grade Serous Ovarian Carcinoma

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-3042
N/A
0DataRank · unranked
2 citations

Austin Miller, Heather A. Lankes, Kwong‐Kwok Wong, William H. Rodgers, David Millan +20 more

Disruption of the gut microbiota attenuates epithelial ovarian cancer sensitivity to cisplatin therapy

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.06.16.155226
N/A
0DataRank · unranked
1 citations

Emily Esakov, Chad Braley, Lexie Trestan, Zahraa Alali, Defne Bayık +14 more

High TGF-β signature predicts immunotherapy resistance in gynecologic cancer patients treated with immune checkpoint inhibition

npj Precision Oncology(2021)10.1038/s41698-021-00242-8
N/A
0DataRank · unranked
56 citations

Ahmed Soliman, Amy Joehlin‐Price, Peter G. Rose, Anda Vlad, Robert P. Edwards +2 more

LCK Regulates Homologous Recombination DNA Repair Identifying a New Target for Sensitizing PARP Inhibitors in HR Proficient Ovarian Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.03.03.433791
N/A
0DataRank · unranked
0 citations

Rashmi Bharti, Chad Braley, Ravi Kumar Alluri, Emily Esakov, Katie Crean-Tate +7 more